Je Jung Lee


Ontology type: schema:Person     


Person Info

NAME

Je Jung

SURNAME

Lee

Publications in SciGraph latest 50 shown

  • 2019-12 Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma in BMC CANCER
  • 2019-01 Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2019-01 18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-12 Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL) in BMC CANCER
  • 2017-12 Computational Modeling of complete HOXB13 protein for predicting the functional effect of SNPs and the associated role in hereditary prostate cancer in SCIENTIFIC REPORTS
  • 2017-09 The clonal origins of leukemic progression of myelodysplasia in LEUKEMIA
  • 2017-01 HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea in HEPATOLOGY INTERNATIONAL
  • 2016-12 Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen in BMC CANCER
  • 2016-10 Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression in ANNALS OF HEMATOLOGY
  • 2016-09 Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment in SCIENTIFIC REPORTS
  • 2016-08 Sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells in EXPERIMENTAL & MOLECULAR MEDICINE
  • 2016-05 The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea in ANNALS OF HEMATOLOGY
  • 2016-03 Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML in ANNALS OF HEMATOLOGY
  • 2016-03 Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study in ANNALS OF HEMATOLOGY
  • 2016-02 Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression in LEUKEMIA
  • 2016-01 Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant in ANNALS OF HEMATOLOGY
  • 2016-01 Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant in ANNALS OF HEMATOLOGY
  • 2016-01 Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen in ANNALS OF HEMATOLOGY
  • 2015-12 Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma in BMC CANCER
  • 2015-02 High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2014-11 Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2014-09 Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study in ANNALS OF HEMATOLOGY
  • 2014-08 Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea–Japan collaborative study in ANNALS OF HEMATOLOGY
  • 2014-05 Decreased body mass index is associated with poor prognosis in patients with multiple myeloma in ANNALS OF HEMATOLOGY
  • 2014 Generation of Multiple Peptide Cocktail-Pulsed Dendritic Cells as a Cancer Vaccine in CANCER VACCINES
  • 2014-01 Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea—experience from 110 patients in ANNALS OF HEMATOLOGY
  • 2013-08 Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia in ANNALS OF HEMATOLOGY
  • 2013-06 Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology in LEUKEMIA
  • 2013-06 IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2013-06 Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial in ANNALS OF HEMATOLOGY
  • 2013-04 Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era in ANNALS OF HEMATOLOGY
  • 2013-03 Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2013-01 Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2012-07 A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma in ANNALS OF HEMATOLOGY
  • 2012-06 Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment in ANNALS OF HEMATOLOGY
  • 2012-04 Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study in ANNALS OF HEMATOLOGY
  • 2012-03 Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer in CELLULAR & MOLECULAR IMMUNOLOGY
  • 2012 In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer in EXPERIMENTAL & MOLECULAR MEDICINE
  • 2012-01 Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy in CELLULAR & MOLECULAR IMMUNOLOGY
  • 2011-12 Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation in ANNALS OF HEMATOLOGY
  • 2011-12 Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins in ANNALS OF HEMATOLOGY
  • 2011-07 Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists in CELLULAR & MOLECULAR IMMUNOLOGY
  • 2011-06 Identification of proteins differentially expressed in gastric cancer cells with high metastatic potential for invasion to lymph nodes in MOLECULES AND CELLS
  • 2010-12 Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study in BMC CANCER
  • 2010-10 Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset in BONE MARROW TRANSPLANTATION
  • 2010-10 Triterpene esters from Uncaria rhynchophylla drive potent IL-12-dependent Th1 polarization in JOURNAL OF NATURAL MEDICINES
  • 2010-09 Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety in ANNALS OF HEMATOLOGY
  • 2010-08 Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells in ANNALS OF HEMATOLOGY
  • 2010-07 Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2010-05 Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study in ANNALS OF HEMATOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.411602.0", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.452901.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.14005.30", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21925.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411597.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410914.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.272242.3", 
            "type": "Organization"
          }
        ], 
        "familyName": "Lee", 
        "givenName": "Je Jung", 
        "id": "sg:person.01204441075.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204441075.42"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:08", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_830.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01204441075.42'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01204441075.42'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01204441075.42'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01204441075.42'


     

    This table displays all metadata directly associated to this object as RDF triples.

    28 TRIPLES      10 PREDICATES      17 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01204441075.42 schema:affiliation N0cdc68535e004704902813408ccbba29
    2 https://www.grid.ac/institutes/grid.14005.30
    3 https://www.grid.ac/institutes/grid.21925.3d
    4 https://www.grid.ac/institutes/grid.272242.3
    5 https://www.grid.ac/institutes/grid.410914.9
    6 https://www.grid.ac/institutes/grid.411597.f
    7 https://www.grid.ac/institutes/grid.452901.b
    8 schema:familyName Lee
    9 schema:givenName Je Jung
    10 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204441075.42
    11 schema:sdDatePublished 2019-03-07T15:08
    12 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    13 schema:sdPublisher N38eb3a3f3a784ffeb8f983f3a2d387ed
    14 sgo:license sg:explorer/license/
    15 sgo:sdDataset persons
    16 rdf:type schema:Person
    17 N0cdc68535e004704902813408ccbba29 schema:affiliation https://www.grid.ac/institutes/grid.411602.0
    18 sgo:isCurrent true
    19 rdf:type schema:OrganizationRole
    20 N38eb3a3f3a784ffeb8f983f3a2d387ed schema:name Springer Nature - SN SciGraph project
    21 rdf:type schema:Organization
    22 https://www.grid.ac/institutes/grid.14005.30 schema:Organization
    23 https://www.grid.ac/institutes/grid.21925.3d schema:Organization
    24 https://www.grid.ac/institutes/grid.272242.3 schema:Organization
    25 https://www.grid.ac/institutes/grid.410914.9 schema:Organization
    26 https://www.grid.ac/institutes/grid.411597.f schema:Organization
    27 https://www.grid.ac/institutes/grid.411602.0 schema:Organization
    28 https://www.grid.ac/institutes/grid.452901.b schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...